Production (Stage)
Akebia Therapeutics, Inc.
AKBA
$2.86
$0.031.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 170.19% | 20.84% | -26.89% | -26.27% | -26.32% |
| Total Receivables | 131.17% | -12.53% | 42.40% | 52.08% | 49.71% |
| Inventory | -22.72% | 3.52% | 11.12% | 14.19% | 23.92% |
| Prepaid Expenses | -91.29% | -72.19% | -62.82% | -46.39% | -38.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 64.49% | 27.23% | 138.88% | 171.44% | 78.26% |
| Total Current Assets | 80.43% | -3.65% | -8.65% | -5.36% | -6.44% |
|
|
|||||
| Total Current Assets | 80.43% | -3.65% | -8.65% | -5.36% | -6.44% |
| Net Property, Plant & Equipment | -38.50% | -35.07% | -32.14% | -29.53% | -55.26% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 7.25% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 7.25% |
| Total Other Intangibles | -- | -100.00% | -80.00% | -66.67% | -57.14% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 225.12% | 200.87% | 602.59% | 431.03% | 125.14% |
| Total Assets | 37.57% | -8.70% | -11.85% | -13.21% | -18.56% |
|
|
|||||
| Total Accounts Payable | 6.53% | 3.72% | 49.30% | -14.17% | -5.53% |
| Total Accrued Expenses | 48.62% | -22.52% | -34.83% | -35.49% | -32.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 91.83% | -59.59% | -41.50% | -74.99% | -75.77% |
| Total Finance Division Other Current Liabilities | 21.48% | 24.61% | 13.36% | 565.19% | 1,515.40% |
| Total Other Current Liabilities | 21.48% | 24.61% | 13.36% | 565.19% | 1,515.40% |
| Total Current Liabilities | 37.21% | -18.98% | -17.56% | 16.40% | -19.84% |
|
|
|||||
| Total Current Liabilities | 37.21% | -18.98% | -17.56% | 16.40% | -19.84% |
| Long-Term Debt | 115.10% | 57.67% | 0.07% | 21.45% | 0.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -72.20% | -60.36% | -51.73% | -45.13% | -72.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -87.01% | -80.98% | 2.50% | -51.66% | -2.59% |
| Total Liabilities | 13.01% | -0.89% | -6.15% | -9.47% | -13.21% |
|
|
|||||
| Common Stock & APIC | 6.07% | 3.22% | 2.23% | 2.14% | 2.23% |
| Retained Earnings | -2.79% | -4.31% | -2.86% | -2.54% | -3.03% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 190.18% | -60.82% | -27.85% | -25.91% | -89.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 190.18% | -60.82% | -27.85% | -25.91% | -89.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 190.18% | -60.82% | -27.85% | -25.91% | -89.92% |
|
|
|||||